Sriram Gubbi, MD

NIH NIDDK
Bethesda, Maryland, United States

Disclosure information not submitted.

Presentation(s):

• SUN-368 - The Association between the Predicted Absorbed Dose and Response to Therapy with Radioiodine using 124I Positron Emission Tomography (PET/CT)

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-385 - Oncocytic Thyroid Cancer Is Characterized by the Highest 68Ga-DOTATATE Uptake Amongst Metastatic Progressive Thyroid Cancers

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• MON-392 - A Thyroid in Disguise : Case of Metastatic Malignant Struma Ovarii

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT